Creeden JF - Search Results

1

Molecular mechanisms underlying rheumatoid arthritis and cancer development and treatment.

Morand S, Staats H, Creeden JF, Iqbal A, Kahaleh B, Stanbery L, Dworkin L, Nemunaitis J. Morand S, et al. Among authors: creeden jf. Future Oncol. 2020 Mar;16(9):483-495. doi: 10.2217/fon-2019-0722. Epub 2020 Feb 26. Future Oncol. 2020. PMID: 32100561 Review.

2

BIRC5 is a target for molecular imaging and detection of human pancreatic cancer.

Liu SH, Hong Y, Markowiak S, Sanchez R, Creeden J, Nemunaitis J, Kalinoski A, Willey J, Erhardt P, Lee J, van Dam M, Brunicardi FC. Liu SH, et al. Cancer Lett. 2019 Aug 10;457:10-19. doi: 10.1016/j.canlet.2019.04.036. Epub 2019 May 3. Cancer Lett. 2019. PMID: 31059751

3

Bifidobacterium spp: the promising Trojan Horse in the era of precision oncology.

Ngo N, Choucair K, Creeden JF, Qaqish H, Bhavsar K, Murphy C, Lian K, Albrethsen MT, Stanbery L, Phinney RC, Brunicardi FC, Dworkin L, Nemunaitis J. Ngo N, et al. Among authors: creeden jf. Future Oncol. 2019 Nov;15(33):3861-3876. doi: 10.2217/fon-2019-0374. Epub 2019 Oct 31. Future Oncol. 2019. PMID: 31668087 Review.

4

Relationship of hypothyroidism and immune response to pegylated IL-10/nivolumab.

Albrethsen M, Creeden J, Morand S, DeBiase J, Berry B, Stanbery L, Edelman G, Nemunaitis J. Albrethsen M, et al. Immunotherapy. 2020 Oct;12(14):1041-1046. doi: 10.2217/imt-2020-0016. Epub 2020 Aug 18. Immunotherapy. 2020. PMID: 32808556

5

Repurposing metformin, simvastatin and digoxin as a combination for targeted therapy for pancreatic ductal adenocarcinoma.

Liu SH, Yu J, Creeden JF, Sutton JM, Markowiak S, Sanchez R, Nemunaitis J, Kalinoski A, Zhang JT, Damoiseaux R, Erhardt P, Brunicardi FC. Liu SH, et al. Among authors: creeden jf. Cancer Lett. 2020 Oct 28;491:97-107. doi: 10.1016/j.canlet.2020.08.002. Epub 2020 Aug 21. Cancer Lett. 2020. PMID: 32829010 Free PMC article.

6

Resident Memory T Cells and Their Effect on Cancer.

Craig DJ, Creeden JF, Einloth KR, Gillman CE, Stanbery L, Hamouda D, Edelman G, Dworkin L, Nemunaitis JJ. Craig DJ, et al. Among authors: creeden jf. Vaccines (Basel). 2020 Oct 1;8(4):562. doi: 10.3390/vaccines8040562. Vaccines (Basel). 2020. PMID: 33019493 Free PMC article. Review.

7

BRCA1/2 signaling and homologous recombination deficiency in breast and ovarian cancer.

Royfman R, Whiteley E, Noe O, Morand S, Creeden J, Stanbery L, Hamouda D, Nemunaitis J. Royfman R, et al. Future Oncol. 2021 Jul;17(21):2817-2830. doi: 10.2217/fon-2021-0072. Epub 2021 Jun 1. Future Oncol. 2021. PMID: 34058833 Review.

8

Homologous recombination proficiency in ovarian and breast cancer patients.

Creeden JF, Nanavaty NS, Einloth KR, Gillman CE, Stanbery L, Hamouda DM, Dworkin L, Nemunaitis J. Creeden JF, et al. BMC Cancer. 2021 Oct 28;21(1):1154. doi: 10.1186/s12885-021-08863-9. BMC Cancer. 2021. PMID: 34711195 Free PMC article. Review.

9

Folate Receptor as a Biomarker and Therapeutic Target in Solid Tumors.

Young O, Ngo N, Lin L, Stanbery L, Creeden JF, Hamouda D, Nemunaitis J. Young O, et al. Among authors: creeden jf. Curr Probl Cancer. 2023 Feb;47(1):100917. doi: 10.1016/j.currproblcancer.2022.100917. Epub 2022 Nov 17. Curr Probl Cancer. 2023. PMID: 36508886 Free article. Review.

10

Emerging Immunotherapeutic and Diagnostic Modalities in Carcinoid Tumors.

Vellani SD, Nigro A, Varatharajan S, Dworkin LD, Creeden JF. Vellani SD, et al. Among authors: creeden jf. Molecules. 2023 Feb 22;28(5):2047. doi: 10.3390/molecules28052047. Molecules. 2023. PMID: 36903295 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

35 results

Search Page